Spinal cord stimulation can reduce pain and restore nerve function among patients with diabetic peripheral neuropathy.

The author has completed the ICMJE form and declares the following conflicts of interest: He received payment for a lecture and for participation in a panel discussion at a symposium arranged by ...

Abbott’s neuromodulation medical director says the company’s spinal cord stimulator, which won gold at the 2025 Edison Awards ...

Researchers at UT Dallas say they’ve made a historic breakthrough in spinal cord injury recovery with a recent implant study.

Once implanted, targeted stimulation in this area can help address symptoms by disrupting pain signals before they can reach the spinal cord or brain. Four out of five people using Abbott’s Proclaim ...

began offering HFX, high-frequency spinal cord stimulation procedures for the treatment of diabetic neuropathy. Abbott’s spinal cord stimulation devices earned FDA approval to address chronic back ...

The REALITY study demonstrates long-term pain relief for patients implanted with Abbott’s proprietary BurstDR™ spinal cord stimulation (SCS) at four-year follow up Data shows that BurstDR is preferred ...

A long-term study of patients treated with one of Medtronic’s spinal cord stimulation devices found that 80% continued to use their devices after five years to manage their pain. Abbott’s Proclaim XR ...

Spinal cord stimulation (SCS) therapies for chronic ... Huygen reported receiving personal fees from Abbott, Saluda, and Grunenthal outside the submitted work. The four other authors reported ...

who were given spinal cord stimulation and sham therapy. Treatment was given via the Abbott octrode neurostimulation system, with leads placed into the T2 to T4 space in the upper thoracic spine ...